

HC Wainwright initiated coverage on Alpha Cognition, noting a new twist on a tried-and-tested treatment paradigm.
You can purchase shares of Alpha Cognition (NASDAQ:ACOG) through any online brokerage.
Other companies in Alpha Cognition’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Alpha Cognition has a consensus price target of $17.40.
The stock price for Alpha Cognition (NASDAQ: ACOG) is $8.15 last updated November 5, 2026 at 4:00 PM EST.
There are no upcoming dividends for Alpha Cognition.
Alpha Cognition does not have any upcoming earnings scheduled.
There is no upcoming split for Alpha Cognition.
Alpha Cognition is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus...